Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

Trial Details

NCT ID

NCT07459309

Phase

NA

Sponsor

Fudan University

Status

RECRUITING

Cancer Type

Liver Cancer

Interventions

• Multimodal Tumor Thermal Ablation

Locations (sample)

• Shanghai, Shanghai Municipality, China|31.22222,121.45806

Key Eligibility Criteria

• Age 18-80 years, regardless of gender;
• Histopathologically confirmed or clinically diagnosed hepatic malignancies, including primary liver cancer and metastatic liver cancer;
• Presence of an image-evaluable target lesion for ablation, with the maximum diameter of the target lesion being 3-5 cm;
• Patient is intolerant to or refuses surgical resection;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.